Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Alnylam Engine for Sustainable Innovation: Leadership in RNAi Platform and Human Genetics Transcript
Good morning, everyone. Thank you for joining us for this RNAi Roundtable. Today, we'll be doing a deep dive into Alnylam's engine for sustainable innovation and discussing our leadership in the RNAi platform and human genetics. I'm Josh Brodsky, Senior Director of Investor Relations and Corporate Communications at Alnylam. And with me today are Vasant Jadhav, Senior Vice President of Research; Kevin Dooley, Associate Director of Research; Paul Nioi, Vice President of Research; and Aimee Deaton, Associate Director of Human Genetics.
Today's RNAi roundtable is part of a series of roundtable webinars that we've been hosting to review progress across our various programs and R&D efforts. Today's event is expected to run approximately 60 minutes. Vasant will moderate the Q&A session at the conclusion of the presentations. If you'd like to submit a question, you can do so at any time during the event by typing your question into the Ask a Question field located on the upper right of the webcast.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
